Author, Investor, Speaker, Mentor
A recent viral Facebook post noted, “Trump said ‘hundreds’ of governors are calling him…& we only have 50.” It’s easy to see why such a post would go viral among Trump opponents–it portrays President Donald Trump as both a liar and an ignoramus, claiming to receive calls from “hundreds” of governors, when, of course, there … Continue reading Why It’s Important To Not Spread Fake News About Donald Trump
One of the major pieces of Covid-19 news today is that Dr. Anders Tegnell, the chief epidemiologist of Sweden’s Public Health Agency told CNBC that he believed that the Swedish capital of Stockholm would achieve herd immunity in the next few weeks, and that his agency’s models project that 20% of the population there is … Continue reading What Is The Human Cost Of Swedish Herd Immunity To Covid-19?
Today, I participated in a 2 1/2 hour Zoom meeting that seemed to fly by. Sound impossible? Yes, if the meeting had been structured like a typical meeting, which is to say, essentially without structure. Sitting on a meandering Zoom call for 2 1/2 hours was one of the punishments Dante placed in the eighth … Continue reading Make Your Zoom Meetings Work Better By “Wasting” More Time
One of the greatest challenges presented by the Covid-19 pandemic is the speed and scope of change. Our lives have changed so much and so quickly that it’s hard to adapt. I’m no exception. I was following the Covid-19 story as I visited Dubai and India in February, but I didn’t grasp its true significance. … Continue reading Adapting to the Covid-19 Pandemic
There is a lot of discussion of hydroxychloroquine (Plaquenil) online, largely because disparate figures such as Elon Musk and President Donald Trump have viewed it as a potential treatment for Covid-19. I can understand the appeal–the drug has been around for decades, is cheap, and can be administered orally. Imagine being able to cure Covid-19 … Continue reading Hydroxychloroquine Clinical Trials
By Chris Yeh and Jennifer Aaker, General Atlantic Professor at the Stanford University Graduate School of Business For millions of Americans, the novel coronavirus (or Covid-19) went from minor, far-off worry to life-altering disaster, seemingly overnight. Perhaps it was three weeks ago, when the NBA suspended its season, followed closely by nearly every other sports … Continue reading Searching For Meaning In The Coronavirus Age
During a call with my fellow Silicon Guild members today, I shared my “three lever” model for addressing the coronavirus crisis. Based on their feedback, I’ve expanded it to four. The key levers that we as a society can pull are: 1. Testing 2. Tracking 3. Treatment 4. Behavior Change These levers are, to a … Continue reading The Four Levers To Combat Coronavirus
One point that most of the “the current shutdown is worse economically than letting 1 million people die” crowd seem to overlook is that the number of deaths is a tiny fraction of those hospitalized. The latest CDC Morbidity and Mortality Weekly Report (MMWR) for the coronavirus showed a ratio of 44 deaths to 121 … Continue reading Covid-19: Inaction Also Has Economic Impact
Like almost everyone else, I am A) intensely worried about the coronavirus (AKA novel coronavirus AKA Covid 19), B) have zero medical expertise and C) am spending ridiculous amounts of time reading through random items on the Internet to try to make sense of what is going on. Also, events are moving so quickly that … Continue reading Coronavirus Caution and Hope
When I checked in three weeks ago, I was just starting to hop and attempt a light jog. In the past three weeks, I’ve been exercising like mad (when I wasn’t busy traveling to Dubai and India) to get ready for my physical therapy appointment today. I’ve even felt good enough to shoot a basketball … Continue reading Achilles Tendon Recovery: 7.75 month update